Trials / Conditions / No Evidence of Disease

No Evidence of Disease

14 registered clinical trials studyying No Evidence of Disease.

Status	Trial	Sponsor	Phase
Withdrawn	Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors NCT03120390	University of Southern California	N/A
Completed	Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma NCT03725449	Rutgers, The State University of New Jersey	N/A
Terminated	Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors NCT03284346	University of Southern California	N/A
Completed	Oxybutynin Chloride in Managing Hot Flashes NCT02961790	Academic and Community Cancer Research United	Phase 3
Completed	Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative NCT02780401	University of Washington	Phase 1
Terminated	MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Wi NCT02735512	University of Southern California	—
Completed	Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening NCT02288416	City of Hope Medical Center	N/A
Completed	Biomarkers in Post-Menopausal Women Receiving Flaxseed NCT01698294	Roswell Park Cancer Institute	N/A
Completed	Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants NCT01497431	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer NCT01230346	City of Hope Medical Center	N/A
Completed	Collection of Bone Marrow From Donors Treated With or Without Filgrastim NCT01149096	Children's Oncology Group	Phase 3
Completed	Study of 9cUAB30 in Healthy Participants NCT00896974	National Cancer Institute (NCI)	Phase 1
Completed	Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers NCT02090933	National Cancer Institute (NCI)	Phase 2
Completed	Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers NCT02099136	National Cancer Institute (NCI)	Phase 2